In the last trading session, 4.78 million Abbvie Inc (NYSE:ABBV) shares changed hands as the company’s beta touched 0.59. With the company’s per share price at $162.54 changed hands at $0.87 or 0.54% during last session, the market valuation stood at $287.80B. ABBV’s last price was a discount, traded about -12.52% off its 52-week high of $182.89. The share price had its 52-week low at $130.96, which suggests the last value was 19.43% up since then. When we look at Abbvie Inc’s average trading volume, we note the 3-month average coming to 5.64 million.

Abbvie Inc (NYSE:ABBV) trade information

Instantly ABBV was in green as seen at the end of in last trading. With action -4.47%, the performance over the past five days has been red. The jump to weekly highs of 169.96 added 0.54% to the stock’s daily price. The company’s shares are showing year-to-date upside of 4.88%, with the 5-day performance at -4.47% in the red. However, in the 30-day time frame, Abbvie Inc (NYSE:ABBV) is -8.62% down.

Abbvie Inc (ABBV) estimates and forecasts

Data shows that the Abbvie Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 9.85% over the past 6 months, a 0.45% in annual growth rate that is considerably lower than the industry average of 3.90%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -5.77%. The 2024 estimates are for Abbvie Inc earnings to increase by 0.32%, but the outlook for the next 5-year period is at 6.28% per year.

ABBV Dividends

Abbvie Inc is expected to release its next quarterly earnings report in May. The 3.73% annual yield figure for the share gives it an annual dividend of 6.06. It is important to note, however, that the 3.73% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.